Current Assets
Prepaid & Other Current
Gilead Sciences Prepaid & Other Current increased by 7.9% to $4.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 53.5%, from $2.83B to $4.34B. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows an upward trend with a 14.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Significant fluctuations may indicate changes in operational scale or timing of large service contracts.
Detailed definition
This category encompasses payments made in advance for goods or services to be received within the next year, such as in...
Peer comparison
Standard across all industries; generally a small portion of total assets for large pharmaceutical companies.
Metric ID:
prepaid_and_other_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.48B | $2.01B | $2.14B | $2.04B | $1.9B | $2.08B | $1.77B | $1.85B | $1.76B | $2.66B | $2.37B | $2.8B | $2.86B | $3.29B | $3.05B | $2.83B | $2.9B | $3.65B | $4.02B | $4.34B |
| QoQ Change | — | +36.0% | +6.5% | -5.0% | -6.6% | +9.3% | -14.6% | +4.1% | -4.8% | +51.5% | -10.8% | +17.9% | +2.0% | +15.1% | -7.1% | -7.3% | +2.5% | +25.7% | +10.4% | +7.9% |
| YoY Change | — | — | — | — | +28.5% | +3.3% | -17.1% | -9.3% | -7.5% | +28.2% | +33.8% | +51.7% | +62.5% | +23.5% | +28.6% | +1.0% | +1.5% | +10.9% | +31.8% | +53.5% |
Range$1.48B – $4.34B
CAGR+25.4%
Avg YoY Growth+20.3%
Median YoY Growth+25.8%
Current Streak4 quarters growth
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's prepaid & other current?
- Gilead Sciences (GILD) reported prepaid & other current of $4.34B in Q1 2026.
- How has Gilead Sciences's prepaid & other current changed year-over-year?
- Gilead Sciences's prepaid & other current increased by 53.5% year-over-year, from $2.83B to $4.34B.
- What is the long-term trend for Gilead Sciences's prepaid & other current?
- Over 5 years (2020 to 2025), Gilead Sciences's prepaid & other current has grown at a 14.9% compound annual growth rate (CAGR), from $2.01B to $4.02B.
- What does prepaid & other current mean?
- Payments made for future services or other minor assets expected to be used within a year.